// App-Quantinova.ai

5016 : Association of androgen receptor (AR) gene status in plasma DNA with outcome on enzalutamide in chemotherapy-naive metastatic castration-resistant prostate cancer (mCRPC): Exploratory results from the PREMIERE trialOn behalf of SOGUG.

Researchers

Presenter

  • Enrique Grande

Principal Investigators

  • Natalia Fernandez Nunez

  • Aranzazu Gonzalez del Alba

  • Begona Mellado

  • Ovidio Fernandez Calvo

  • Maria Jose Mendez

  • Miguel Angel Climent

  • Ignacio Duran

  • Enrique Gallardo

  • Angel Rodriguez Sanchez

  • Carmen Santander

  • M Isabel Saez

  • Javier Puente

  • Maria Piedad Fernandez Perez

  • Vincenza Conteduca

  • Daniel Wetterskog

  • Gerhardt Attard

  • Daniel Castellano

  • Enrique Gonzalez-Billalabeitia

Medical Centers

  • Hospital Universitario Ramon y Cajal, Madrid, Spain

  • Institut Catala d'Oncologia, Hospital Universitario German Trias i Pujol, Badalona, Spain

  • Hospital Universitario Lucus Augusti, Lugo, Spain

  • Son Espases University Hospital, Palma De Mallorca, Spain

  • Hospital Clinic Barcelona, Barcelona, Spain

  • Complejo Hospitalario Universitario de Ourense, Orense, Spain

  • Reina Sofia University Hospital, Cordoba, Spain

  • Instiuto Valenciano de Oncologia, Valencia, Spain

  • Instituto de Biomedicina de Sevilla, IBiS/Hospital Universitario Virgen del Rocio/CSIC/Universidad de Sevilla, Seville, Spain

  • Hospital Universitari Parc Tauli, Barcelona, Spain

  • Hospital of Leon, Leon, Spain

  • H. Universitario Miguel Servet, Zaragoza, Spain

  • CRIS Cancer Foundation Prostate Cancer Research Group, Institute of Biomedical Research in Malaga/ CNIO-IBIMA Genitourinary Cancer Research Unit, H Universitarios Virgen de la Victoria y Regional de Malaga, Malaga, Spain

  • Hospital Universitario Clinico San Carlos, Madrid, Spain

  • Department of Hematology and Medical Oncology, Hospital G. Universitario Morales Meseguer, IMIB-Arrixaca, Universidad Catolica San Antonio, Murcia, Spain

  • IRCCS - IRST (Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori), Meldola, Italy

  • The Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, United Kingdom

  • The Institute of Cancer Research & The Royal Marsden, London, Spain

  • Medical Oncology Department. Hospital 12 de Octubre, Madrid, Spain

Locations

  • Spain

  • United Kingdom

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Nephrology

Disease

  • N/A

Biomarkers

  • Circulating tumor cells

Drug/Treatment

  • Enzalutamide

  • Androgen Tear

Outcome

  • Unknown

Study Design

  • N/A

Phase

  • NA

Study Id's

  • NCT02288936

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved